Screening for germ-line mutations in the NF2 gene

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• Neurofibromatosis type 2 (NF2) is an inherited disorder predisposing to nervous system tumors, such as meningiomas and schwannomas.
• The NF2 gene, located on chromosome 22, is implicated in NF2 pathogenesis and exhibits tumor suppressor activity.
• Identifying NF2 mutations is crucial for understanding disease mechanisms and developing targeted therapies.

Purpose of the Study:

• To develop and validate a screening method for detecting point mutations in the NF2 gene.
• To identify germ-line mutations in a cohort of unrelated NF2 patients.
• To investigate genotype-phenotype correlations in NF2.

Main Methods:

• Denaturing Gradient Gel Electrophoresis (DGGE) was employed for efficient screening of NF2 gene mutations.
• The method covered 95% of the coding sequence and 90% of intron/exon junctions.
• 91 unrelated NF2 patients were analyzed for germ-line mutations.

Main Results:

• The DGGE screening successfully identified 32 distinct germ-line mutations in the NF2 gene among the 91 patients.
• Mutations were predominantly located in the 5' half of the gene, often leading to truncated proteins.
• A correlation was observed between milder disease manifestations and mutations preserving the C-terminal end of the NF2 protein.

Conclusions:

• The developed DGGE method is effective for screening NF2 mutations, identifying causative mutations in a significant portion of patients.
• The findings suggest frequent involvement of promoter or intronic regions, not detected by this coding-sequence-focused method, in a subset of NF2 cases.
• Genotype-phenotype correlations indicate that the location and nature of NF2 mutations influence disease severity.